0·07)–5·42 (−97·18 to 231·08)–27·30 (−97·63 to 169·46)0·81 (0·06 to 2·86)0·75 (0·00 to 1·90)–7·10 (−97·19 to 231·03)–26·75 (−97·31 to 156·14)··Kidney cancer0·13 (0·08 to 0·20)0·17 (0·11 to 0·26)34·51 (−0·86 to 60·98)2·17 (−24·86 to 21·78)3·08 (1·96 to 4·80)4·06 (2·61 to 6·04)31·80 (−2·65 to 56·85)2·54 (−25·05 to 22·42)··Thyroid cancer0·02 (0·01 to 0·03)0·02 (0·01 to 0·04)23·74 (−45·68 to 71·02)–5·05 (−56·07 to 32·19)0·48 (0·23 to 0·95)0·58 (0·31 to 0·95)22·78 (−42·37 to 72·84)–2·72 (−53·99 to 35·78)··Non-Hodgkin lymphoma0·07 (0·03 to 0·14)0·08 (0·04 to 0·14)14·80 (−48·12 to 89·49)–11·36 (−59·15 to 44·86)1·93 (0·88 to 3·84)2·17 (1·02 to 3·70)12·11 (−53·36 to 89·82)–9·92 (−61·71 to 50·34)··Multiple myeloma0·04 (0·02 to 0·07)0·04 (0·02 to 0·08)20·90 (−36·98 to 86·20)–8·58 (−52·81 to 40·23)0·80 (0·33 to 1·52)0·96 (0·43 to 1·68)19·88 (−41·55 to 79·48)–7·25 (−53·09 to 39·99)··Acute lymphoid leukaemia0·01 (0·01 to 0·03)0·02 (0·01 to 0·03)21·67 (−42·96 to 84·50)–0·50 (−52·49 to 49·86)0·60 (0·33 to 1·16)0·72 (0·44 to 1·15)20·31 (−42·71 to 77·73)2·35 (−50·81 to 53·90)··Chronic lymphoid leukaemia0·02 (0·01 to 0·03)0·02 (0·01 to 0·03)11·87 (−40·76 to 59·76)–17·04 (−56·19 to 17·59)0·31 (0·17 to 0·60)0·34 (0·20 to 0·57)9·98 (−47·66 to 65·06)–15·46 (−59·33 to 28·08)··Acute myeloid leukaemia0·04 (0·02 to 0·06)0·04 (0·03 to 0·07)20·64 (−33·37 to 72·72)–5·40 (−47·60 to 32·17)1·08 (0·62 to 1·88)1·27 (0·79 to 2·04)17·65 (−34·43 to 64·82)–3·94 (−45·68 to 33·05)··Chronic myeloid leukaemia0·01 (0·01
